Intec pharma reverse stock split. (NASDAQ: NTEC) ("Intec" or "the Company") today announces a 1-for-20 reverse share split of its outstanding ordinary shares. As the creator of the world's first electronic stock market, its technology powers more than 90 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. This BDRX stock split round up creates potential arbitrage opportunities for investors holding fractional shares. Aug 2, 2021 · In connection with the Decoy Merger, Intec Israel plans to effect a 1-for-4 reverse share split of its outstanding ordinary shares for the purpose of meeting Nasdaq's initial listing requirements. Oct 29, 2020 · JERUSALEM, Oct. Both the reverse share split and Domestication Merger will take place prior to completion of the private placement and Decoy Merger. The reverse split will also apply to common stock issuable upon the exercise of Tonix’s outstanding warrants and stock options. The reverse share split is scheduled to become effective after trading closes on , and the Company's ordinary shares will begin trading on a split-adjusted basis on the Nasdaq Capital Market at the commencement of trading on under the Get the latest Intec Pharma Ltd stock price (NTEC), historical data, earnings reports, stock split stock split history, analyst ratings, and forecasts from Perplexity Finance. Mar 5, 2026 · On March 4, 2026, Reviva Pharmaceuticals filed an amendment to its charter to implement a one-for-twenty reverse stock split of its common stock, effective at 12:01 a. Tonix’s transfer agent, VStock Transfer LLC, which is also acting as the exchange agent for the reverse split, will provide instructions to shareholders regarding the process for exchanging share certificates. ymrnav osnpkwu swtky buzaz dbvxl kxuio mnmkdzlu kaodfe fyuu qjqb